SPL UNCLASSIFIED SECTION
NOTE: This solution is hypertonic - See WARNINGS and PRECAUTIONS. LifeShield® Abboject® Syringe Fliptop Container - Ansyr™ II Plastic Syringe - Rx only
DESCRIPTION
50% Dextrose Injection, USP is a sterile, nonpyrogenic, hypertonic solution of dextrose in water for injection for intravenous injection as a fluid and nutrient replenisher. Each mL of fluid ...
CLINICAL PHARMACOLOGY
When administered intravenously this solution restores blood glucose levels in hypoglycemia and provides a source of carbohydrate calories. Carbohydrate in the form of dextrose may aid in ...
INDICATIONS AND USAGE
50% Dextrose Injection is indicated in the treatment of insulin hypoglycemia (hyperinsulinemia or insulin shock) to restore blood glucose levels. The solution is also indicated, after dilution ...
CONTRAINDICATIONS
A concentrated dextrose solution should not be used when intracranial or intraspinal hemorrhage is present, nor in the presence of delirium tremens if the patient is already dehydrated. Dextrose ...
WARNINGS
50% Dextrose Injection is hypertonic and may cause phlebitis and thrombosis at the site of injection. Significant hyperglycemia and possible hyperosmolar syndrome may result from too rapid ...
PRECAUTIONS
Do not use unless the solution is clear and seal is intact. Discard unused portion. Electrolyte deficits, particularly in serum potassium and phosphate, may occur during prolonged use of ...
ADVERSE REACTIONS
Hyperosmolar syndrome, resulting from excessively rapid administration of concentrated dextrose may cause mental confusion and/or loss of consciousness. Reactions which may occur because of the ...
OVERDOSAGE
In the event of overhydration or solute overload during therapy, re-evaluate the patient and institute appropriate corrective measures. See WARNINGS and PRECAUTIONS.
DOSAGE AND ADMINISTRATION
For peripheral vein administration - Injection of the solution should be made slowly. The maximum rate at which dextrose can be infused without producing glycosuria is 0.5 g/kg of body ...
HOW SUPPLIED
50% Dextrose Injection, USP is supplied in single-dose containers as follows: Unit of SaleConcentration - NDC 0409-4902-34 - 25 g/50 mL - Bundle containing 10 LifeShield® Abboject ...
SPL UNCLASSIFIED SECTION
Abboject® is a trademark of the Abbott group of companies. LifeShield® is the trademark of ICU Medical, Inc. and is used under license. Distributed by Hospira, Inc., Lake Forest, IL 60045 ...
PRINCIPAL DISPLAY PANEL - 50 mL Syringe Label - 0409-7517-66
50% DEXTROSE - 50 mL Single-dose - Rx only - NDC 0409-7517-66 - 50% DEXTROSE Injection, USP - 25 g/50 mL (0.5 g/mL) For intravenous use. Usual dosage: See insert. Sterile, nonpyrogenic. 2.53 mOsmol/mL ...
PRINCIPAL DISPLAY PANEL - 50 mL Syringe Carton - 0409-7517-66
50 mL - NDC 0409-7517-66 - 50% DEXTROSE - Injection, USP - 25 g/50 mL (0.5 g/mL) Ansyr®II - Unit of Use Syringe - Rx only - LOT #####AA - EXP DMMMYYYY - Hospira - �-� PRESS AND PULL TO OPEN ▶
PRINCIPAL DISPLAY PANEL - 50 mL Syringe Label - 0409-4902-64
50% DEXTROSE - 50 mL Single-dose - Rx only - NDC 0409-4902-64 - 50% DEXTROSE Inj., USP - 25 g/50 mL (0.5 g/mL) For intravenous use. Usual dosage: See insert. Sterile, nonpyrogenic. 2.53 mOsmol/mL (calc. ...
PRINCIPAL DISPLAY PANEL - 50 mL Syringe Carton - 0409-4902-64
50 mL - NDC 0409-4902-64 - 50% DEXTROSE - Injection, USP - 25 g/50 mL - (0.5 g/mL) LIFESHIELD® Glass - ABBOJECT® Unit of Use Syringe - with male luer lock - adapter and - 18-Gauge protected needle - Rx ...
PRINCIPAL DISPLAY PANEL - 50 mL Vial Label - 0409-6648-16
50 mL Single-dose - 50% Dextrose - Injection, USP - 25 grams/50 mL - (0.5 g/mL) Distributed by Hospira, Inc. Lake Forest, IL 60045 USA - Hospira
PRINCIPAL DISPLAY PANEL - 50 mL Vial Tray - 0409-6648-02
50 mL Single-dose Fliptop Vial - Rx only - NDC 0409-6648-02 - Contains 25 of NDC 0409-6648-16 - 50% Dextrose Injection, USP - 25 grams/50 mL - (0.5 g/mL) Hospira
INGREDIENTS AND APPEARANCE
Product Information
